GlassScriptPhysician profile
Peter Biegler
NPI 1164683363
$9,697.40
in general payments reported to CMS, 2019-2025
12 companies · $4,066 in 2025
The $4,066 reported for 2025 was more than what 84% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $424 · 2021: $183 · 2022: $532 · 2023: $1,800 · 2024: $2,693 · 2025: $4,066.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,071 · Food and Beverage: $3,488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,071.06 |
| Food and Beverage | $3,487.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $5,970.93 | 2020-2025 | Indigo System, Penumbra System |
| W. L. Gore & Associates, INC. | $2,052.64 | 2020-2024 | Gore Tag Thoracic Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo, Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Medtronic, INC. | $433.90 | 2021-2025 | Endurant Iis, Mvp, Hawkone |
| Inari Medical, INC. | $329.01 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Histosonics, INC. | $286.28 | 2025 | |
| Sirtex Medical INC | $219.34 | 2022-2025 | Sir-Spheres Microspheres |
| Boston Scientific Corporation | $182.29 | 2021-2025 | Cryoablation Needles, General - Therapies, General - Interventional Oncology |
| Bard Peripheral Vascular, INC. | $154.19 | 2020-2025 | Rotarexs 6 F X 135 Cm |
| Stryker Corporation | $27.86 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Argon Medical Devices, INC. | $24.18 | 2022 | |
| Ethicon US, LLC | $16.78 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Biegler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.